According to our (Global Info Research) latest study, the global Fluorescence Molecular Imager market size was valued at US$ 139 million in 2025 and is forecast to a readjusted size of US$ 224 million by 2032 with a CAGR of 7.0% during review period.
Fluorescence molecular imager is specialized optical imaging platforms designed to visualize and quantify fluorescent molecular signals in live small animals and related ex vivo samples. These systems typically integrate highly sensitive cooled CCD, sCMOS, EMCCD or InGaAs/SWIR detectors, excitation light sources, emission filters, spectral acquisition modules, light-tight imaging chambers, animal anesthesia and temperature-control components, and dedicated image analysis software. The core functions include planar fluorescence imaging, combined bioluminescence and fluorescence imaging, near-infrared I and near-infrared II/SWIR imaging, fluorescence molecular tomography, and optical signal co-registration with X-ray or CT anatomical information. In preclinical research, these instruments are used to monitor tumor growth, biodistribution, pharmacokinetics, cell trafficking, immune and inflammatory responses, infection models, vascular imaging and reporter gene expression in a non-invasive and longitudinal manner. The product category is positioned between traditional laboratory optical imaging instruments and high-end preclinical multimodal imaging platforms, with demand primarily driven by academic core facilities, pharmaceutical and biotechnology companies, CROs, translational medicine centers and animal imaging laboratories.
Based on our research, fluorescence molecular imager is a specialized life science instrumentation market rather than a broad fluorescence detection market. The appropriate reporting boundary should focus on live small-animal imaging, preclinical research workflows, fluorescence or optical molecular signals, and system-level instruments. This distinction is important because the term “fluorescence molecular imager” can otherwise be confused with fluorescence microscopes, gel and blot imaging systems, flow cytometry, clinical fluorescence-guided surgery platforms, or reagent-only suppliers. The mainstream product format is typically not a pure fluorescence-only device; most established systems integrate fluorescence imaging with bioluminescence imaging, spectral filters, animal handling, quantitative software and, in some premium configurations, X-ray or CT co-registration. Official product lines from IVIS, Lago/Ami, Pearl Trilogy and PhotonIMAGER illustrate that the competitive core remains high-sensitivity signal detection, reliable animal workflow, quantitative software and modular upgradeability.
Demand is primarily supported by oncology models, biodistribution and pharmacokinetics, cell tracking, immune and inflammatory disease models, infection research, drug delivery and translational research platforms. Traditional 2D BLI/FLI systems are already in a mature replacement cycle, while NIR-II/SWIR, 3D fluorescence tomography and optical-plus-CT systems represent the main upgrade directions. The market is constrained by academic funding cycles and capital equipment procurement processes, but it benefits from pharmaceutical R&D, CRO preclinical services, animal imaging core facilities and the need for longitudinal non-invasive in vivo readouts.
From the perspective of technology and competitive trends, the industry is shifting from basic signal acquisition toward deeper penetration, higher quantitative accuracy, faster imaging workflows and stronger multimodal integration. NIR-II/SWIR fluorescence imaging, fluorescence molecular tomography, optical-plus-CT co-registration, multispectral unmixing, high-throughput animal handling and AI-assisted quantitative analysis are becoming the main directions for product upgrades. Established leaders are likely to defend their positions through installed base, validated workflows, software ecosystems and global service capabilities, while specialized smaller players can still gain opportunities by focusing on differentiated technology routes such as NIR-II/SWIR imaging, 3D fluorescence localization or compact cost-effective systems. Competitive pressure will increasingly come from both ends of the market: premium global brands will continue to strengthen high-end research platforms, while regional manufacturers, especially in China and South Korea, are expected to compete more actively in price-sensitive and locally serviced segments. Although alternative modalities such as micro-PET/SPECT, photoacoustic imaging, MRI and advanced microscopy may overlap with some preclinical research needs, they differ in cost, sensitivity, probe systems, spatial resolution and workflow compatibility. Therefore, the near-term competitive relationship is more likely to be complementary rather than fully substitutive. The key long-term challenge for fluorescence molecular imaging system suppliers will be to prove that their platforms can deliver reproducible, quantitative and biologically meaningful in vivo data under increasingly demanding preclinical research standards.
This report is a detailed and comprehensive analysis for global Fluorescence Molecular Imager market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fluorescence Molecular Imager market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fluorescence Molecular Imager market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fluorescence Molecular Imager market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Fluorescence Molecular Imager market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fluorescence Molecular Imager
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fluorescence Molecular Imager market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Revvity, Inc., Bruker Corporation, LI-COR, Inc., Biospace Lab S.A., Berthold Technologies GmbH & Co. KG, Vieworks Co., Ltd., Photon etc. Inc., RWD Life Science Co., Ltd., Shanghai Clinx Science Instruments Co., Ltd., Guangzhou Biolight Biotechnology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fluorescence Molecular Imager market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Wavelength Imaging
Multi-wavelength Imaging
Market segment by Detector
CCD-based System
sCMOS-based System
EMCCD-based System
InGaAs / SWIR-based System
Other Detector System
Market segment by Spectral Range
Visible Fluorescence
Far-red Fluorescence
NIR-I Fluorescence
NIR-II / SWIR Fluorescence
Multi-band Fluorescence
Market segment by Application
Chemical
Medicine
Other
Major players covered
Revvity, Inc.
Bruker Corporation
LI-COR, Inc.
Biospace Lab S.A.
Berthold Technologies GmbH & Co. KG
Vieworks Co., Ltd.
Photon etc. Inc.
RWD Life Science Co., Ltd.
Shanghai Clinx Science Instruments Co., Ltd.
Guangzhou Biolight Biotechnology Co., Ltd.
Vilber
MILabs B.V.
TriFoil Imaging, Inc.
Nirmidas Biotech, Inc.
Endress+Hauser Group
NeoScience Co., Ltd.
Guangzhou Guangyi Shengwu Keji Youxian Gongsi
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fluorescence Molecular Imager product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fluorescence Molecular Imager, with price, sales quantity, revenue, and global market share of Fluorescence Molecular Imager from 2021 to 2026.
Chapter 3, the Fluorescence Molecular Imager competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fluorescence Molecular Imager breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Fluorescence Molecular Imager market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fluorescence Molecular Imager.
Chapter 14 and 15, to describe Fluorescence Molecular Imager sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Fluorescence Molecular Imager. Industry analysis & Market Report on Fluorescence Molecular Imager is a syndicated market report, published as Global Fluorescence Molecular Imager Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Fluorescence Molecular Imager market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.